ID   Lipo246
AC   CVCL_4U73
SY   lipo246
DR   Wikidata; Q54902553
RX   PubMed=21060307;
RX   PubMed=26373732;
CC   Doubling time: ~1.7 days (PubMed=26373732).
CC   Derived from site: In situ; Retroperitoneal space; UBERON=UBERON_0003693.
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
RX   PubMed=26373732; DOI=10.1007/s13277-015-4050-6;
RA   Mersch, Sabrina
RA   Riemer, Jasmin C.
RA   Schlunder, Philipp M.
RA   Ghadimi, Markus Philipp
RA   Ashmawy, Hany
RA   Mohlendick, Birte
RA   Topp, Stefan A.
RA   Arent, Tanja
RA   Kropil, Patric
RA   Stoecklein, Nikolas H.
RA   Gabbert, Helmut Erich
RA   Knoefel, Wolfram Trudo
RA   Krieg, Andreas
RT   "Peritoneal sarcomatosis: site of origin for the establishment of an
RT   in vitro and in vivo cell line model to study therapeutic resistance
RT   in dedifferentiated liposarcoma.";
RL   Tumor Biol. 37:2341-2351(2016).
//
RX   PubMed=21060307; DOI=10.1038/labinvest.2010.185; PMCID=PMC3058694;
RA   Peng, Ting-Sheng
RA   Zhang, Ping-Yu
RA   Liu, Jeffrey Jue-Hui
RA   Nguyen, Theresa
RA   Bolshakov, Svetlana V.
RA   Belousov, Roman
RA   Young, Eric D.
RA   Wang, Xiao-Ke
RA   Brewer, Kari
RA   Lopez-Terrada, Dolores H.
RA   Oliveira, Andre M.
RA   Lazar, Alexander J.F.
RA   Lev, Dina Chelouche
RT   "An experimental model for the study of well-differentiated and
RT   dedifferentiated liposarcoma; deregulation of targetable tyrosine
RT   kinase receptors.";
RL   Lab. Invest. 91:392-403(2011).
//